| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,822 |
3,784 |
$147K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,393 |
2,338 |
$128K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,216 |
896 |
$18K |
| 99385 |
|
123 |
102 |
$6K |
| 99401 |
|
478 |
330 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
104 |
99 |
$5K |
| 99384 |
|
48 |
44 |
$4K |
| 96127 |
|
2,634 |
1,611 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
108 |
67 |
$3K |
| 99408 |
|
670 |
478 |
$3K |
| 99051 |
|
214 |
206 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,941 |
1,602 |
$3K |
| H0049 |
Alcohol and/or drug screening |
583 |
413 |
$2K |
| 81002 |
|
1,653 |
1,134 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
56 |
50 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
42 |
41 |
$1K |
| 99050 |
|
103 |
97 |
$1K |
| 99386 |
|
12 |
12 |
$863.76 |
| 96160 |
|
152 |
115 |
$325.00 |
| 80074 |
|
352 |
244 |
$278.10 |
| 69210 |
|
20 |
15 |
$257.18 |
| 86703 |
|
404 |
260 |
$238.96 |
| 92551 |
|
24 |
24 |
$190.21 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
405 |
287 |
$176.85 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
416 |
288 |
$150.96 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
405 |
282 |
$148.07 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
77 |
45 |
$142.39 |
| S9470 |
Nutritional counseling, dietitian visit |
146 |
126 |
$112.54 |
| 86593 |
|
356 |
231 |
$40.37 |
| 99173 |
|
39 |
38 |
$16.54 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
154 |
80 |
$0.00 |
| 99072 |
|
47 |
40 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
12 |
12 |
$0.00 |
| 86696 |
|
22 |
13 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
126 |
59 |
$0.00 |
| 2010F |
|
162 |
110 |
$0.00 |
| 1220F |
|
645 |
438 |
$0.00 |
| 2000F |
|
153 |
139 |
$0.00 |
| 1126F |
|
447 |
331 |
$0.00 |
| 99000 |
|
83 |
64 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
77 |
63 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
15 |
14 |
$0.00 |
| 97802 |
|
13 |
13 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
82 |
66 |
$0.00 |
| 4293F |
|
18 |
16 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
26 |
13 |
$0.00 |